News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
AI-based fetal monitoring to prevent perinatal brain injury
A new AI-driven approach to fetal brain health monitoring will enable early detection of fetal distress, allowing for timely interventions to prevent brain damage and reducing unnecessary medical interventions, thanks to Monash Institute of Medical Engineering (MIME) project grant support.… Read more
-
Next-generation degradable 3D meshes to repair POP
A debilitating condition affecting one in four women is desperately crying out for a solution, and the next generation of treatments to repair the damage of pelvic organ prolapse (POP) has just come a big step closer.… Read more
-
Double success for Hudson Institute with Brockhoff Foundation
A pair of exciting Hudson Institute research projects has received funding for the next two years from the Jack Brockhoff Foundation.… Read more
-
Genetic analysis CAPS search for a cure
A rare and debilitating group of autoinflammatory diseases is closer to a cure thanks to a world first genetic analysis project at Hudson Institute.… Read more
-
Research winners good news for kids with cancer
Hudson Institute’s Centre for Cancer Research is a major winner in the Medical Research Future Fund (MRFF) 2024 Paediatric Brain Cancer Research grants.… Read more
-
Too much of a good thing: fine-tuning newborn resuscitation
Latest research at Hudson found that a simple change in how oxygen therapy is given can help protect the babies brain during newborn resuscitation.… Read more
-
Breakthrough IBD treatment heads into clinical trials
People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most difficult to treat conditions associated with the disease.… Read more
-
Stem Cells: Hope on the horizon for preterm babies
Pioneering Australian research, undertaken by a collaboration of Monash Health’s Monash Children’s Hospital, The School of Clinical Sciences at Monash University, and Hudson Institute of Medical Research, has successfully demonstrated the feasibility and safety of using a baby’s own cord blood-derived cells as a potential treatment for extremely preterm infants.… Read more
-
NHMRC and ARC Grant success in 2024
Hudson Institute researchers have had some great success in the recent NHMRC Ideas and ARC Discovery Grant rounds.… Read more
-
Uncovering the cellular secrets of RNA editing
Professor Carl Walkley heads the RNA Biology and Innate Immune Sensing Research Group at Hudson Institute of Medical Research and their latest research, published in Science Immunology, sheds new light on these crucial processes.… Read more
